Emil Frei Dies

Emil Frei, an oncologist who worked at the National Cancer Institute, the MD Anderson Cancer Center, and the Dana-Farber Cancer Institute, has died, the New York Times reports. He was 89. The Times notes that, in the mid-1950s, Frei was among the first to promote the use of combination chemotherapy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Mary Lyon Dies

This Week in PNAS

To Court

Very Own Mouse

Papers Pulled

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.